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Summary
Crystallization remains a critical step in X-ray struc-
ture determination. Because it is not generally possi-
ble to rationally predict crystallization conditions,
commercial screens have been developed which sam-
ple a wide range of crystallization space. While this
approach has proved successful in many cases, a sig-
nificant number of proteins fail to crystallize despite
being soluble and monodispersed. It is established
that chemical modification can facilitate the crystalli-
zation of otherwise intractable proteins. Here we de-
scribe amethod for the reductive methylation of lysine
residues which is simple, inexpensive, and efficient,
and report on its application to ten proteins. We
describe the effect of methylation on the physico-
chemical properties of these proteins, and show that
it led to diffraction-quality crystals from four proteins
and structures for three that had hitherto proved
refractory to crystallization. The method is suited to
both low- and high-throughput laboratories.
Introduction
Crystallography remains the leading method for solving
in atomic detail the structures of macromolecules and
their complexes. However, success rests entirely on
obtaining diffraction-quality crystals and the process
of crystallization remains a hit-and-miss affair, typically
involving screening hundreds of conditions. It appears
from a number of large-scale analyses (see, for instance,
Fogg et al., 2006 and Canaves et al., 2004) that at pres-
ent the success rate remains no more than 50%.
It is self-evident that molecular flexibility will tend to
be detrimental to the formation of a highly ordered crys-
tal lattice. For proteins, such flexibility can arise from
large-scale motions of domains or portions of the poly-
peptide chain such as surface loops and chain termini.
Such motions may be reduced or eliminated by redesign
of the protein construct (for instance, to remove disor-
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4 Lab address: http://www.strubi.ox.ac.ukdered terminal extensions) or by binding to a ‘‘crystalli-
zation chaperone’’ which might be as large as an anti-
body fragment (Iwata et al., 1995) or as small as a
chemical inhibitor (Ren et al., 1995). In addition, if poorly
ordered crystals are obtained, diffraction can some-
times be improved by controlled dehydration (see, for
instance, Esnouf et al., 1998 and Heras et al., 2003). Bio-
informatics and experimental approaches can be used
to detect and perhaps control large-scale disorder (Es-
nouf et al., 2006; Yang et al., 2005; Geerlof et al., 2006;
Stroh et al., 2005) and the use of thermostable versions
of proteins may also help (Adams et al., 2003; Lesley
et al., 2002), as these might be expected to be more rigid
at temperatures lower than experienced in vivo.
At the other extreme, small motions such as those due
to flexible, solvent-exposed amino acid side chains can
be equally disruptive to a well-ordered crystal lattice.
One approach to this problem has been to selectively
mutate these residues to smaller hydrophobic residues.
Initially described by Lawson et al. (1991), where the
diffraction quality of human ferritin crystals was greatly
improved by the mutation of an exposed lysine to a
glutamine, microengineering of flexible surface residues
has produced some remarkable crystallization suc-
cesses. The Derewenda laboratory has championed
such approaches and the state of the art is described
in a recent review (Derewenda and Vekilov, 2006). Par-
ticular attention has been given to the mutation of large
charged residues such as lysine (Longenecker et al.,
2001; McElroy et al., 1992) and glutamate (Mateja
et al., 2002). While such ‘‘surface-entropy-reduction mu-
tagenesis’’ is now an established technique, it remains
a time- and labor-intensive procedure which requires
the production of modified expression constructs. In ad-
dition, in the absence of structural knowledge, it is quite
possible that key stabilizing salt bridges might be inad-
vertently targeted for destruction.
Surface engineering of proteins by chemical modifica-
tion offers a radically different approach to reducing sur-
face entropy and has led to some dramatic successes,
none more so than the first application by the Rayment
laboratory to a fragment of myosin (Rayment et al.,
1993). This approach offers several advantages: first,
recloning, expression, and purification steps are elimi-
nated; second, modification of the mature protein
avoids the possibility of inducing misfolding of the na-
scent polypeptide chain (Rypniewski et al., 1993); and
third, only those residues on the exposed surface of
the protein will be modified, not those protected in the
protein core or buried in strong protein-protein inter-
faces. Conversely, such a ‘‘shotgun’’ method will in-
discriminately label residues which may be critical for
biological function. The most common approach to
chemical modification has been the reductive methyla-
tion of free amino groups in which primary amines
(i.e., lysine residues and the N terminus) are modified
to tertiary amines. Originally used as a method of iso-
tope labeling (Means and Feeney, 1968; Rice and
Means, 1971), this has proven value for protein crystalli-
zation, allowing, in certain instances, the formation of
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ously proved refractory to crystallization (Kobayashi
et al., 1999; Kurinov et al., 2000; Rayment et al., 1993;
Saxena et al., 2006; Schubot and Waugh, 2004).
Here we describe a simple generic protocol for the
methylation of lysines residues, developed in the Oxford
Protein Production Facility (OPPF) and the Division of
Structural Biology at Oxford University, which has
been adopted as a routine crystallization rescue strat-
egy. The procedure is cheap and robust, and mass
spectrometry provides a straightforward readout of the
extent of methylation. We describe its application to
a set of ten proteins. The process yielded a homoge-
neous modification for nine of these; four have formed
diffraction-quality crystals leading to three high-resolu-
tion structures to date.
The Protocol
The method used is derived from that published previ-
ously (Rayment, 1997; Rayment et al., 1993). The meth-
ylation reaction is performed overnight in 50 mM HEPES
(pH 7.5), 250 mM NaCl at protein concentrations of 1 mg/
ml or less. Twenty microliters freshly prepared 1 M dime-
thylamine-borane complex (ABC; Fluka product 15584)
and 40 ml 1 M formaldehyde (made from 37% stock;
Fluka product 33220) are added per ml protein solution,
and the reactions are gently mixed and incubated at
277K for 2 hr. A further 20 ml ABC and 40 ml formaldehyde
are added and the incubation continued for 2 hr. Follow-
ing a final addition of 10 ml ABC, the reaction is incubated
overnight at 277K. In some cases, the reaction leads to
a significant amount of precipitated protein (occasion-
ally over 50%), which is removed by centrifugation be-
fore purification of the soluble methylated protein by
size-exclusion chromatography columns (S75 or S200
Superdex 16/60 on A¨kta express FPLC systems; GE
Healthcare) pre-equilibrated in 20 mM Tris-HCl (pH
7.5), 200 mM NaCl. Appropriate peak fractions are
pooled and concentrated in centrifugal concentrators
(Vivascience) to appropriate concentrations (as deter-
mined by a precrystallization test; PCT; Hampton
Research). The concentrated protein is then often buffer
exchanged into 20 mM Tris-HCl using a micro Bio-Spin
column (Bio-Rad), and crystallization experiments are
set up immediately.
Compared to previous protocols, the concentration of
the protein in the reaction is markedly reduced, to 1 mg/
ml or less, as higher concentrations often led to protein
precipitation and significant loss of material. As a conse-
quence, the formaldehyde and reductant are in greater
excess over the number of free amines on the protein,
producing no adverse effects and perhaps helping to
ensure the homogeneous modification observed (see
below). Similarly, the reaction is not quenched with
a high concentration of ammonium sulfate, as this also
frequently led to precipitation; instead, quenching is
performed by the Tris-HCl buffer used for the postreac-
tion size-exclusion chromatography by reaction with the
amines of the buffer (in line with the observation of Ray-
ment, 1997 that any primary amine can be used to
quench). This purification step also separates the pro-
tein from excess reagents and monitors protein quality
and oligomeric state.Application to a Test Set of Proteins
To test whether our protocol for the reductive methyla-
tion of lysines could be used as a generic rescue
strategy, a cohort of ten proteins which had proved
refractory to structural analysis was selected. These
proteins, from a number of source organisms, were se-
lected on the basis that they were soluble, stable, and,
in seven out of the ten cases, did not crystallize. Eight
of the test set (both native and selenomethionine
[SeMet] derivatives) were produced by the OPPF pipe-
line (described in both Ren et al., 2005 and Siebold
et al., 2005) and two came from the Division of Structural
Biology. The proteins are listed in Table 1. All were >95%
pure (as judged by SDS-PAGE analysis) before the
methylation reaction.
Changes in the oligomeric state, following methyla-
tion, were observed during the postreaction size-exclu-
sion chromatography purification step for three of the
ten proteins (Table 1). Samples were removed pre- and
postreaction for electrospray ionization mass spectrom-
etry analysis (an increase in mass of 28 Da correspond-
ing to the modification of one lysine residue or the
N-terminal amine). For four of the ten proteins not all
the potential sites (taken to be the number of lysine res-
idues plus one) were methylated, implying that those
residues remaining unmodified were inaccessible to
the reagents, either buried in the protein core or masked
by bound ligand at the active site in the case of the viral
methyltransferase and bacterial alanine racemase (see
Table 1). Certain of the proteins were also characterized
by isoelectric focusing (IEF) (performed according to
the manufacturer’s instructions on a vertical system us-
ing pH 3–10 IEF precast gels with the manufacturer’s
buffers; Novex; Invitrogen) and broad-range isoelectric
point (pI) markers (GE Healthcare). For those proteins
with a high pI, the pI was reduced by approximately
one unit upon methylation, while for those with a lower
pI, there was little change (Table 1).
Crystallization experiments were set up and moni-
tored using the crystallization facility in the OPPF
(Brown et al., 2003; Walter et al., 2003, 2005). Of the
ten proteins methylated, five gave crystals. For four of
the proteins, the crystals were of diffraction quality.
For two of these, no crystals had been previously ob-
tained; and in one further case the crystal quality was
markedly improved (see Table 1), resulting in three suc-
cessful structure determinations. For one protein the
unit cell dimensions have been reduced, presumably
due to the reduction in oligomeric state, while in the
last case there is a change in crystal morphology, and
analysis is still in progress. We will briefly describe the
three successful structural analyses.
Bacilus anthracis Alanine Racemase
The enzyme alanine racemase from Bacillus anthracis
was targeted as part of the ongoing collaborative struc-
tural proteomics initiative between the OPPF and York
Structural Biology laboratory (Au et al., 2006). An
N-terminal His6-tagged form of the protein was ex-
pressed, purified and the tag removed, using estab-
lished protocols (Ren et al., 2005; Siebold et al., 2005).
The protein showed two distinct oligomeric states in
gel filtration, assumed to be tetrameric and dimeric. Ex-
tensive crystallization trials (approximately 800 condi-
tions) on both oligomeric forms (in the presence of the
Ways & Means
1619Table 1. Data for the Cohort of Ten Proteins Subject to Methylation
Name of
Proteina
MW (kDa)
N/Mb pI Cb/N/M
No. of
Sites R (P)c
Protein
Conc. N/Md
Oligomeric
State N/Me
Crystal
N/M
Diffraction
N/M Comments
BA BA0252
(alanine
racemase)
43.8/44.4 6.2/5.5/5.2 20 (21) 22/15 M/M no/yes NA/2.8 A˚ Structure solved.
Methylation essential
for crystallization.
MHV NSP9 13.2/13.5 8.5/9.5/8.6 11 (11) 14/8 D/D no/yes NA/2.3 A˚ Structure solved.
Methylation essential
for crystallization.
MVEV NS5A
(methyl
transferase)
31.2/31.7 9.5/>10/9.2 19 (22) 9/6 M/M yes/yes no/2.1 A˚ Structure solved. Protein
precipitates partially
in reaction. Methylation
dramatically improves
crystal quality.
Bacteriophage
V8 P1
86.8/87.8 6.1/5.6/5.8 36 (38) 10/4 2f yes/yes 4.0 A˚/4.0 A˚ Crystal structure not
solved due to large unit
cell. Cell dimensions
change on methylation.
SARS NSP1
domain
14.6/14.8 5.9/2/2 7 (7) 8/9 M/M no/no NA
SARS NSP10 16.9/17.1 6.9/2/2 7/8 (8) 2/4 M/M no/no NA Methylated as two
species.
SARS NSP15 38.1/38.8 6.0/2/2 26 (26) 12/8 M/M no/no NA
FoxP2 337–716 43.0/43.5 5.8/2/2 16 (16) 8/6 D/M no/no NA
FoxP2 337–433 12.8/13.0 7.6/2/2 7 (7) 24/9 XX/D no/no NA
RSVN 44.4/45.2 6.5/2/2 28 (31) 12/8 X/X yes/yes 10 A˚/10 A˚ Changed crystal
morphology and
condition.
NA, not applicable.
a BA, Bacillus anthracis; MHV, murine hepatitis virus; MVEV, Murray Valley encephalitis virus; SARS, severe acute respiratory syndrome; FoxP2,
Forkhead box P2; RSVN, respiratory syncytial virus nucleoprotein.
b N, native, unmodified protein; M, methylated; C, calculated.
c R, number of sites methylated; P, number of potential sites.
d Protein concentration (mg/ml).
e Oligomeric state was as estimated from size-exclusion chromatography. M, monomer; D, dimer; X, decamer; XX, possible 16-mer (MW
w150 kDa).
f The precise oligomeric state is ill determined, but reduced upon methylation.cofactor pyridoxal 50-phosphate) at both 15 and 22 mg/
ml yielded no crystal hits and so reductive methylation
was attempted. Mass spectrometry analysis revealed
that 20 out of 21 potential sites were fully methylated, re-
ducing the pI from 5.5 to 5.2. Methylated dimeric protein
atw15 mg/ml crystallized at 298K within a few hours in
high salt conditions. Crystals grown from optimized
conditions were used for data collection and the struc-
ture was determined by molecular replacement to
2.9 A˚. In the crystal, four lysine residues are located at
the crystallographic interfaces between the dimers. It
is presumably the modification of these residues which
allows crystal formation. A paper describing the struc-
ture in greater detail is currently in preparation (K.-F.A.,
J.R., T.S.W., C.M., K. Harlos, D.I.S., and R.M. Esnouf,
unpublished data).
MVEV Methyltransferase
The flavivirus Murray Valley encephalitis virus (MVEV) is
a target of the ongoing ‘‘Vizier’’ structural genomics
initiative (http://www.vizier-europe.org/). The methyl-
transferase domain of nonstructural protein 5 (NS5)
was chosen for structural analysis. Based on bioinfor-
matic analysis (Albeck et al., 2006; Esnouf et al., 2006;
Yang et al., 2005) and alignment with a related structure
from Dengue virus (Egloff et al., 2002), a number of con-
structs were cloned and expressed. Although several
constructs gave soluble protein, no crystals suitablefor X-ray diffraction analysis were grown. Methylation
of the protein modified 19 out of 22 sites and produced
three different crystal forms, all of which diffracted to
better than 2.1 A˚. The majority of crystals grew from
either 20% PEG3350 or high salt conditions. Upon
methylation, the pI of the protein shifted from >10 to
9.2. In one crystal form, nine lysines are involved in crys-
tal contacts (Figure 1). A paper describing the structure
of this protein is currently in preparation (R.A., J.R., A.V.,
T.S.W., D. Alderton, R. Hurrelbrink, S. Fuller, R.J.O.,
D.I.S., and J.M.G., unpublished data).
MHV NSP9
As part of an ongoing structural proteomics project on
coronaviruses (Meier et al., 2006), a cohort of proteins
from the murine hepatitis virus (MHV) genome have
been targeted for structural analysis. The small dimeric
NSP9 protein (formerly NSP6) is a homolog of the
SARS NSP9, binds RNA, and is part of the replication
complex (Sutton et al., 2004). Prior to methylation, no
crystals of MHV NSP9 were obtained despite extensive
screening efforts (native and SeMet-labeled protein
were tested at different concentrations). After reductive
methylation, all 11 potential methylation sites were
modified and the pI of the protein was reduced from
9.5 to 8.6. Methylated forms of both native and SeMet-
labeled protein crystallized readily from high salt con-
ditions. Further crystal optimization led to structure
Structure
1620Figure 1. Examples of Methylated Lysines
from MVE Methyltransferase
(A) An example of the interaction between
a methylated lysine and a glutamate residue
at a crystal contact. An overview of the pack-
ing of molecules of MVE methyltransferase in
one of the three crystal forms solved (space
group P21, a = 46.4 A˚, b = 68.3 A˚, c = 82.0 A˚,
b = 98.4) is drawn in the top panel, with the
two molecules in the crystallographic asym-
metric unit colored red and green, respec-
tively. The close-up in the bottom panel
shows the hydrophobic packing of the ali-
phatic components of the side chains lysine
177 and glutamate 166.
(B) An example of well-defined electron den-
sity for a methylated lysine (K15) involved in
a crystal contact with the main chain of
a neighboring molecule. The figure was pro-
duced using PyMOL (http://www.pymol.org).determination by molecular replacement at 2.3 A˚ resolu-
tion (C.M., D.I.S., and J.M.G., unpublished data). Five
lysine residues are located at interfaces, forming crystal
contacts between dimers.
Discussion
A simple protocol for the modification of lysine residues
has been tested on ten protein samples which had pre-
viously proved intractable to structure solution. In three
cases, the structure of the methylated protein could be
determined.
Mass spectrometry proves an excellent quality-
control step; an incomplete reaction due to perished re-
agents can be readily observed as a series of ion species
14 Da apart (corresponding to addition of single methyl
groups). Used with proteolysis and mass spectrometry,
methylation could also be used to define candidate res-
idues for the mutagenesis approach to surface engi-
neering (Derewenda and Vekilov, 2006). It has been
reported that methylated proteins usually display re-
duced solubility (Schubot and Waugh, 2004). In our
test cases the concentration required for crystallization,
as judged by the use of the PCT, is reduced to between
two thirds and one third of that for the unmodified sam-
ples. We also observed a shift to higher apparent molec-
ular weight as determined by the size-exclusion clean-
up step, and is in line with previous reports (Kurinov
et al., 2000; Schubot and Waugh, 2004). In addition, in
several cases, there was a shift from higher to lower
order oligomeric states (Table 1).
Another effect on the biophysical properties of the
proteins upon methylation is a reduction in the pI. In
the three cases where methylation led to structure de-
termination, a measurable reduction in pI was observed.
Intriguingly, these observations correlate with data pre-viously reported for proteins of Thermotoga maritima,
where plotting predicted pI and average hydropathy re-
veals that the majority of the proteins whose structures
were solved have calculated pIs below 7.0 (Canaves
et al., 2004). It is possible that this in part reflects a
bias in the commercial crystallization screens currently
available; however, the trend has been seen with other
proteomes (Au et al., 2006). An alternative explanation
for the tendency for proteins with a high pI to fail to crys-
tallize might be that they have a high concentration of
surface lysines. These side chains are likely, through
entropic effects, to destabilize the crystal lattice. Con-
versely, the hydrophobic nature of the dimethylated
lysines will favor protein-protein interactions. In line
with this, well-ordered lysines are found to be involved
in crystal contacts in all three of the proteins solved,
and it is well known that hydrophobic interactions of
methylated lysines drive the formation of certain protein
complexes, notably in the interaction of histone tails
with chromodomains (Flanagan et al., 2005). The change
in chemistry of the free amide groups affects other bio-
physical properties, reducing the solubility of proteins
and sometimes changing the oligomeric state. Overall,
the effects of methylation on the behavior of proteins
in crystallization experiments are likely to be complex;
nevertheless, the significant success rate we have ob-
served in a set of test proteins has led us to adopt meth-
ylation as a simple generic rescue tool.
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